Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-025155

Senior VP - CMO sold 62,500 shares at $7.03 ($439,375)

  • Senior VP - CMO acquired 62,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sheridan William P Senior VP - CMO 2018-08-09 Option exercise +62,500 $1.42 $88,750 85,713 D: show line 1 in the form
Sheridan William P Senior VP - CMO 2018-08-09 Sale −62,500 $7.03 $439,375 23,213 D: show line 2 in the form
Open-market sales · 62,500 sh · avg $7.03 · $439,375

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sheridan William P Senior VP - CMO 2018-08-09 Option exercise · Emp. Stock Option (Right to Buy) −62,500 0 D: show line 3 in the form
Loading xslF345X03/form4.xml…